Cambridge Associates’s Alerian MLP ETF AMLP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-79,219
Closed -$2.44M 41
2020
Q1
$2.44M Buy
79,219
+20,964
+36% +$710K 0.23% 37
2019
Q4
$2.48M Buy
+58,255
New +$2.45M 0.28% 36
2017
Q4
Sell
-76,353
Closed -$4.28M 34
2017
Q3
$4.28M Hold
76,353
0.52% 24
2017
Q2
$4.57M Hold
76,353
0.72% 24
2017
Q1
$4.85M Buy
76,353
+23,251
+44% +$1.49M 0.81% 22
2016
Q4
$3.35M Hold
53,102
0.7% 20
2016
Q3
$3.37M Hold
53,102
0.71% 20
2016
Q2
$3.38M Hold
53,102
0.79% 20
2016
Q1
$2.9M Hold
53,102
1.38% 14
2015
Q4
$3.2M Buy
53,102
+29,298
+123% +$1.83M 1.67% 12
2015
Q3
$1.49M Hold
23,804
0.87% 13
2015
Q2
$1.85M Hold
23,804
0.88% 13
2015
Q1
$1.97M Hold
23,804
0.91% 11
2014
Q4
$2.08M Buy
+23,804
New +$2.16M 1.05% 10

Other funds holding AMLP

Cambridge Associates's AMLP Position: Q2 2020 in Review

Cambridge Associates sold out of Alerian MLP ETF (AMLP) in Q2 2020, closing a stake of 79,219 shares — an estimated $2.44M sold.

Cambridge Associates first reported a position in AMLP in Q4 2014 and held it in 14 quarters. The position peaked at $4.85M in Q1 2017. 413 funds tracked by Wall St. Rank hold AMLP as of Q2 2020.

  • Cambridge Associates reported no remaining Alerian MLP ETF position as of Q2 2020 after selling out during the quarter.
  • Cambridge Associates sold 79,219 Alerian MLP ETF shares in Q2 2020, an estimated $2.44M.
  • Cambridge Associates first reported a position in Alerian MLP ETF in Q4 2014 and held it in 14 quarters.
  • Cambridge Associates's Alerian MLP ETF position peaked at $4.85M in Q1 2017.
  • 413 funds tracked by Wall St. Rank held Alerian MLP ETF as of Q2 2020.

Based on Cambridge Associates's 13F filing for Q2 2020, filed 12 Aug 2020.